샘플 요청 목록

 카트 문의
시장보고서
상품코드
1798957

세계의 의료용 마이크로칩 시장

Microchips in Medicine
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 285 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의료용 마이크로칩 세계 시장은 2030년까지 27억 달러에 달할 전망

2024년에 15억 달러로 추정되는 의료용 마이크로칩 세계 시장은 2024년부터 2030년까지 CAGR 10.8%로 성장하여 2030년에는 27억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 약물전달 용도는 CAGR 12.2%를 기록하며 분석 기간 종료까지 18억 달러에 달할 것으로 예측됩니다. 홈 모니터링 용도 부문의 성장률은 분석 기간 동안 CAGR 8.1%로 추정됩니다.

미국 시장은 4억 130만 달러로 추정, 중국은 CAGR 14.9%로 성장 예측

미국의 의료용 마이크로칩 시장은 2024년에 4억 130만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 14.9%로 2030년까지 5억 6,910만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 7.7%와 9.6%로 예측됩니다. 유럽에서는 독일이 CAGR 약 8.6%로 성장할 것으로 예측됩니다.

세계의 의료용 마이크로칩 시장 - 주요 동향과 촉진요인 정리

마이크로칩이 의료 진단과 치료의 미래를 어떻게 바꿀 것인가?

의료용 마이크로칩(이식형 또는 섭취형 의료용 칩이라고도 함)은 의료 전문가들이 다양한 건강 상태를 진단, 모니터링 및 치료하는 방법을 재정의하고 있습니다. 쌀알 크기 이하인 이 반도체 기반 디바이스는 활력 징후를 모니터링하고, 약물을 목표 지점에 전달하거나 환자가 처방된 요법을 준수하는지 확인하는 데 사용됩니다. 알약에 내장된 섭취 가능한 센서 칩은 섭취 시 데이터를 전송하여 약물의 섭취에 대한 실시간 피드백을 제공할 수 있습니다. 한편, 이식형 칩은 장기적인 생체신호 추적을 통해 심혈관질환, 간질, 당뇨병 등 만성질환을 모니터링합니다.

이 칩은 생체적합성 재료, 미세전자기계시스템(MEMS), 저전력 반도체, 무선 데이터 전송이 융합된 칩입니다. 병원 방문이나 부피가 큰 장비를 필요로 하는 기존 모니터링 기술과 달리, 마이크로칩은 지속적이고 수동적이며 원격으로 건강 모니터링을 제공합니다. 전 세계 헬스케어가 맞춤형 의료로 전환되고 있는 가운데, 이 칩을 통해 의사는 실시간으로 수집되는 환자별 데이터를 기반으로 치료 요법을 조정할 수 있습니다.

헬스케어 분야에서 마이크로칩의 채택을 촉진하는 기술적 혁신은 무엇일까?

재료 과학, 나노 가공, 미세유체 공학의 중요한 기술 혁신은 의료 분야에서 마이크로 칩의 적용을 촉진하고 있습니다. 이 칩은 현재 pH, 포도당 수준, 전해질, 효소 활성 등 생화학 신호를 감지할 수 있는 바이오 센서를 탑재하고 있습니다. 전력 효율이 크게 향상되고, 칩은 소형 배터리와 에너지 수확 메커니즘(압전 시스템, 열전 시스템 등)을 사용하여 몇 개월에서 몇 년 동안 작동할 수 있습니다. 초저전력 집적회로(IC)와 무선 시스템온칩(SoC)은 스마트폰과 클라우드 플랫폼에 원활한 데이터 전송을 가능하게 합니다.

가장 유망한 분야 중 하나는 스마트 약물전달 시스템으로, 생물학적 트리거나 원격 조작에 반응하여 약물을 방출하도록 칩이 미리 프로그래밍되어 있는 스마트 약물전달 시스템입니다. 이는 암 치료 및 호르몬 치료의 전임상시험에서 검증되었습니다. 심박조율기나 신경자극기에 내장된 마이크로칩이 심장 리듬과 신경 활동의 연속적인 데이터를 중계합니다. 최근 동향에는 수분 보충, 체온, 전기생리학적 신호를 비침습적으로 추적할 수 있는 피부 이식형 마이크로칩과 전자 문신도 포함됩니다.

또한, 블록체인 기반의 안전한 데이터 전송과 AI 기반 분석으로 칩에서 생성된 데이터가 예측 진단과 집단 건강관리에서 실용화되고 있습니다. FDA와 같은 규제 기관은 이러한 칩의 안전성과 유용성을 인정하고 있으며, 이로 인해 임상 적용이 가속화되고 있습니다.

마이크로칩 기술 도입률이 가장 높은 의료 분야는?

만성질환 관리는 가장 중요한 응용 분야 중 하나입니다. 예를 들어, 당뇨병 환자들은 마이크로칩이 장착된 지속적 혈당 측정기(CGM)를 통해 인슐린 펌프와 의료 서비스 제공자에게 논스톱으로 데이터를 전송할 수 있는 혜택을 누리고 있습니다. 심장학에서는 심박조율기나 제세동기에 내장된 이식형 칩이 부정맥, 심장박동 변동, 심부전의 초기 징후를 추적하는 데 사용되고 있습니다. 신경학적 응용 분야에는 발작, 두개내압, 척수 활동을 실시간으로 모니터링하는 칩이 포함됩니다.

제약 분야에서는 섭취 가능한 마이크로칩을 임상시험 및 컴플라이언스 모니터링에 활용하고 있습니다. 프로테우스 디지털 헬스(Proteus Digital Health)는 이 분야의 선구자로서, 조현병 및 C형 간염 치료제의 복약 순응도를 확인하는 데 활용되고 있는 복용 성공 여부를 알려주는 알약을 출시하였습니다. 종양학 분야에서는 종양 내 약물전달 및 열 소작 안내를 위한 마이크로칩이 테스트되고 있습니다. 정형외과 및 인공관절 분야에서는 임플란트에 칩을 삽입하여 치유율, 하중역학, 감염 마커를 모니터링하고 있습니다.

수의학은 가축과 반려동물의 추적, 진단, 백신 모니터링에 RFID 마이크로칩이 사용되는 또 다른 병행 성장 분야입니다. 지역별로는 북미가 연구개발, 임상시험, 상용화를 주도하고 있으며, 환자 데이터 규제와 공중보건 통합에 대한 관심이 높은 유럽이 그 뒤를 잇고 있습니다. 아시아태평양, 특히 중국, 일본, 한국은 디지털 헬스 인프라와 반도체 혁신에 대한 정부의 노력으로 빠르게 부상하고 있습니다.

세계 의료용 마이크로칩 시장의 성장을 촉진하는 요인은 무엇일까?

세계 의료용 마이크로칩 시장의 성장은 만성질환의 증가, 환자 중심의 의료 서비스 제공으로의 전환, 원격 모니터링 기술 도입 확대 등 여러 요인에 의해 이루어지고 있습니다. 실시간 연속 진단에 대한 수요로 인해 의료 시스템은 마이크로 칩을 주류 치료 경로에 통합하기 시작했습니다. 센서와 칩의 소형화 및 저가화로 진입장벽이 낮아져 입원 및 외래를 불문하고 폭넓은 적용이 가능해졌습니다.

헬스케어에서 스마트폰, 웨어러블, IoT 플랫폼의 이용이 병행하여 증가하고 있으며, 칩을 이용한 진단을 위한 디지털 생태계가 형성되고 있습니다. COVID-19 사태는 원격의료의 수용을 가속화하고 비접촉식 모니터링의 필요성을 부각시켰습니다. 제약사들은 특히 정신건강 및 감염성 질환 분야에서 약물 순응도를 개선하기 위해 경구용 제제에 칩을 삽입하는 경우가 늘고 있습니다.

결과 기반 상환과 예방 의료를 지향하는 헬스케어 부문의 움직임은 마이크로칩이 제공하는 지속적인 모니터링 툴을 더욱 촉진하고 있습니다. 미국, 영국, 유럽 일부 지역에서는 디지털 치료제 및 원격 진단에 대한 상환 코드가 확대되어 상업적 실행 가능성을 높이고 있습니다. 데이터 프라이버시와 생체적합성에 대한 우려가 안전한 아키텍처와 불활성 물질로 해결됨에 따라, 마이크로칩을 활용한 헬스케어의 미래는 제도적, 기술적, 시장적 모멘텀이 계속 증가하고 있습니다.

부문

용도(약물전달 용도, 재택 모니터링 용도, 기타 용도), 최종 용도(병원 최종 용도, 조사 최종 용도, 기타 최종 용도)

조사 대상 기업 사례

  • Abbott Laboratories
  • Becton, Dickinson and Company(BD)
  • BioTelemetry(a Philips company)
  • Biotronik
  • Boston Scientific Corporation
  • Capsule Technologies(A Qualcomm Life Company)
  • Cepheid(a Danaher company)
  • Cochlear Limited
  • Dexcom Inc.
  • GE HealthCare
  • Hillrom(now part of Baxter)
  • Honeywell Life Sciences
  • Implantica
  • Masimo Corporation
  • Medtronic Plc
  • Microchip Biotechnologies Inc.
  • NXP Semiconductors
  • PerkinElmer(now part of Revvity)
  • Siemens Healthineers
  • Zimmer Biomet

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.09.04

Global Microchips in Medicine Market to Reach US$2.7 Billion by 2030

The global market for Microchips in Medicine estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Drug Delivery Application, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Home Monitoring Application segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$401.3 Million While China is Forecast to Grow at 14.9% CAGR

The Microchips in Medicine market in the U.S. is estimated at US$401.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$569.1 Million by the year 2030 trailing a CAGR of 14.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.7% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.

Global Microchips in Medicine Market - Key Trends & Drivers Summarized

How Are Microchips Transforming the Future of Medical Diagnostics and Therapeutics?

Microchips in medicine-also known as implantable or ingestible medical chips-are redefining how healthcare professionals diagnose, monitor, and treat a wide array of health conditions. These semiconductor-based devices, often the size of a grain of rice or smaller, are being used to monitor vital signs, deliver drugs at targeted locations, or verify patient adherence to prescribed regimens. Ingestible sensor chips embedded in pills can transmit data once ingested, providing real-time feedback on medication intake. Meanwhile, implantable chips monitor chronic diseases such as cardiovascular disorders, epilepsy, or diabetes through long-term biosignal tracking.

These chips represent a fusion of biocompatible materials, micro-electromechanical systems (MEMS), low-power semiconductors, and wireless data transmission. Unlike traditional monitoring techniques that require hospital visits or bulky equipment, microchips offer continuous, passive, and remote health surveillance. As global healthcare pivots toward personalized medicine, these chips enable physicians to adjust treatment regimens based on patient-specific data collected in real time-minimizing adverse drug reactions and maximizing therapeutic efficacy.

What Technological Breakthroughs Are Driving Adoption of Microchips in Healthcare?

Significant innovations in materials science, nanofabrication, and microfluidics are propelling the deployment of microchips in medical settings. Chips now feature biosensors capable of detecting biochemical signals such as pH, glucose levels, electrolytes, or enzyme activity. Power efficiency has been vastly improved, allowing chips to function for months or even years using miniature batteries or energy harvesting mechanisms (e.g., piezoelectric or thermoelectric systems). Ultra-low-power integrated circuits (ICs) and wireless systems-on-chip (SoCs) enable seamless data transmission to smartphones or cloud platforms.

One of the most promising areas is smart drug delivery systems, wherein chips are pre-programmed to release drugs in response to biological triggers or via remote control. This has been validated in preclinical studies for cancer treatment and hormone therapy. Another area of rapid growth is biosignal telemetry, where microchips embedded in pacemakers or neurostimulators relay continuous data on heart rhythms or neural activity. Recent developments also include skin-interfaced microchips and electronic tattoos capable of non-invasively tracking hydration, temperature, and electrophysiological signals.

Furthermore, blockchain-based secure data transmission and AI-driven analytics are making chip-generated data actionable in predictive diagnostics and population health management. Regulatory bodies such as the FDA are increasingly acknowledging the safety and utility of such chips, thereby accelerating clinical adoption.

Which Medical Fields Are Seeing the Highest Adoption Rates of Microchip Technologies?

Chronic disease management is among the most significant application areas. Diabetic patients, for instance, benefit from continuous glucose monitors (CGMs) equipped with microchips, enabling non-stop data relay to insulin pumps or healthcare providers. In cardiology, implantable chips inside pacemakers or defibrillators are used to track arrhythmias, heart rate variability, and early signs of heart failure. Neurological applications include chips that monitor seizures, intracranial pressure, or spinal cord activity in real time.

The pharmaceutical sector is integrating ingestible microchips into drug trials and compliance monitoring. Proteus Digital Health pioneered this segment, launching a pill that signals successful ingestion-a feature being utilized to verify adherence in schizophrenia and hepatitis C treatments. The oncology field is testing microchips for intra-tumoral drug delivery or thermal ablation guidance. In orthopedic and prosthetic applications, chips are being embedded in implants to monitor healing rates, load dynamics, and infection markers.

Veterinary medicine is another parallel growth segment where RFID microchips are used for tracking, diagnostics, and vaccine monitoring in livestock and pets. Geographically, North America leads in R&D, clinical trials, and commercialization, followed by Europe with a strong focus on patient data regulation and public health integration. Asia-Pacific-particularly China, Japan, and South Korea-is emerging rapidly due to government initiatives in digital health infrastructure and semiconductor innovation.

What Is Fueling Growth in the Global Microchips in Medicine Market?

The growth in the global microchips in medicine market is driven by several factors, including the rising burden of chronic diseases, a shift toward patient-centric healthcare delivery, and increased adoption of remote monitoring technologies. The demand for real-time, continuous diagnostics has prompted healthcare systems to integrate microchips into mainstream treatment pathways. Miniaturization and affordability of sensors and chips are reducing entry barriers, enabling broader deployment across both inpatient and outpatient settings.

A parallel rise in the use of smartphones, wearables, and IoT platforms in healthcare is creating a supportive digital ecosystem for chip-enabled diagnostics. The COVID-19 pandemic accelerated telehealth acceptance and highlighted the need for contactless monitoring-reinforcing the value of ingestible or implantable microchips. Pharmaceutical companies are increasingly embedding chips in oral formulations to improve drug compliance, especially in mental health and infectious disease segments.

The healthcare sector’s movement toward outcome-based reimbursement and preventative care further incentivizes continuous monitoring tools that microchips offer. Reimbursement codes for digital therapeutics and remote diagnostics are expanding across the US, UK, and parts of Europe, bolstering commercial viability. As concerns over data privacy and biocompatibility are addressed through secure architectures and inert materials, the microchip-enabled healthcare future continues to gain institutional, technological, and market momentum.

SCOPE OF STUDY:

The report analyzes the Microchips in Medicine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Drug Delivery Application, Home Monitoring Application, Other Applications); End-Use (Hospitals End-Use, Research Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • BioTelemetry (a Philips company)
  • Biotronik
  • Boston Scientific Corporation
  • Capsule Technologies (A Qualcomm Life Company)
  • Cepheid (a Danaher company)
  • Cochlear Limited
  • Dexcom Inc.
  • GE HealthCare
  • Hillrom (now part of Baxter)
  • Honeywell Life Sciences
  • Implantica
  • Masimo Corporation
  • Medtronic Plc
  • Microchip Biotechnologies Inc.
  • NXP Semiconductors
  • PerkinElmer (now part of Revvity)
  • Siemens Healthineers
  • Zimmer Biomet

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Microchips in Medicine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Development of Smart Pills and Ingestible Microchips Throws the Spotlight on Digital Medicine
    • Rising Need for Continuous Patient Monitoring Drives Adoption of Implantable Microchips
    • Advances in Biocompatible Semiconductor Materials Enhance Medical Integration of Microchips
    • Growth in Remote Patient Management Solutions Spurs Demand for Chip-Enabled Wearable Devices
    • Use of Microchips for Drug Release Timing Enhances Precision Therapy Protocols
    • Surge in Interest in Digital Biomarkers Expands Use of Embedded Chips for Vital Sign Capture
    • Integration of NFC and RFID Technologies Drives Development of Smart Packaging in Pharma
    • Expansion of Electronic Health Monitoring Systems Strengthens Business Case for Chip-Enabled Devices
    • Innovation in Energy Harvesting and Wireless Charging Enhances Microchip Usability in Medicine
    • Growing Investment in Neurotechnology Spurs Development of Brain-Implanted Monitoring Chips
    • Advances in Lab-on-Chip Diagnostics Drive Miniaturized Point-of-Care Testing Applications
    • Regulatory Approvals for Ingestible Sensors Expand Commercialization of Diagnostic Microchips
    • Collaborations with Pharma Firms Accelerate Development of Companion Diagnostics Using Chips
    • Increase in Clinical Trials Using Sensor-Based Monitoring Enhances Microchip Market Penetration
    • Focus on AI Integration Within Chipsets Supports Personalized and Predictive Healthcare
    • Growth in Geriatric Care Needs Propels Use of Monitoring Chips in Long-Term Care Settings
    • Use of Blockchain and Smart Contracts in Chip-Enabled Drug Traceability Strengthens Compliance
    • Expansion of Telehealth Infrastructure Globally Spurs Use of Chip-Based Mobile Health Devices
    • Development of Closed-Loop Drug Delivery Systems Integrates Microchips for Feedback Control
    • Public Acceptance of Biometric Implants Opens Pathways for Wider Use of Microchips in Medicine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microchips in Medicine Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microchips in Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Delivery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Delivery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Drug Delivery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Home Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Home Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Home Monitoring Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Microchips in Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microchips in Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Microchips in Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Microchips in Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제